Suvoda, Clinical

Suvoda LLC Pennsylvania

17.01.2023 - 09:03:02

Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA

customer satisfaction survey, which found that 92% of customers are likely to recommend Suvoda to colleagues.

In 2022, Suvoda continued to expand its global presence, now supporting trials in nearly 80 countries and adding talent at all levels across the globe, bringing the total number to almost 900 employees. The company made important hires, including industry luminaries and technology executives with proven experience building extensible and scalable solutions who are working closely with Suvoda's eClinical experts to design innovative, yet practical solutions that manage the increasing complexities of global clinical trials.

"We expect 2023 to continue to be challenging for clinical trial sponsors as financial markets tighten and sponsors face pressure to initiate trials quickly, show progress early, and execute flawlessly," said Suvoda's Chief Operating Officer Robert Hummel. "Suvoda is building a platform that helps reduce these risks for sponsors while also keeping the patient central to the mission by making it easier for them to participate in trials. In the end, our goal is to help sponsors develop therapies for patients who need them most."

About Suvoda

Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest, Romania, and Tokyo, Japan. The company consistently boasts a Net Promoter Score (NPS) of close to 70, far exceeding the technology industry average of 50, and has been selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries. To learn more, visit suvoda.com. Follow Suvoda on Twitter and LinkedIn

For information contact:

Mara Conklin, (847) 340-6823
mconklin@teamclarus.com

Kathy Zoeller, (312) 485-2422
kathy@mattsonpr.com

 

Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/suvoda-2022-clinical-trials-surge-20-as-it-expands-offerings-to-include-econsent-and-ecoa-301722661.html

@ prnewswire.co.uk